Familial temporal lobe epilepsy with psychic auras associated with a novel <i>LGI1</i> mutation

  • P. Striano
    From the Muscular and Neurodegenerative Diseases Unit (P.S.), “G. Gaslini” Institute, University of Genoa, Genova; CNR-Istitute of Neurosciences (G.B., L.R., C.N.), Department of Biology (E.L., L.V., S.C.E.T.), University of Padua, Padova; Epilepsy Centre (L.S., A.C., S.S.), Department of Neurological Sciences, Federico II University, Napoli; and Department of Neurological Sciences (R.M.), Bellaria Hospital, Bologna, Italy.
  • G. Busolin
    From the Muscular and Neurodegenerative Diseases Unit (P.S.), “G. Gaslini” Institute, University of Genoa, Genova; CNR-Istitute of Neurosciences (G.B., L.R., C.N.), Department of Biology (E.L., L.V., S.C.E.T.), University of Padua, Padova; Epilepsy Centre (L.S., A.C., S.S.), Department of Neurological Sciences, Federico II University, Napoli; and Department of Neurological Sciences (R.M.), Bellaria Hospital, Bologna, Italy.
  • L. Santulli
    From the Muscular and Neurodegenerative Diseases Unit (P.S.), “G. Gaslini” Institute, University of Genoa, Genova; CNR-Istitute of Neurosciences (G.B., L.R., C.N.), Department of Biology (E.L., L.V., S.C.E.T.), University of Padua, Padova; Epilepsy Centre (L.S., A.C., S.S.), Department of Neurological Sciences, Federico II University, Napoli; and Department of Neurological Sciences (R.M.), Bellaria Hospital, Bologna, Italy.
  • E. Leonardi
    From the Muscular and Neurodegenerative Diseases Unit (P.S.), “G. Gaslini” Institute, University of Genoa, Genova; CNR-Istitute of Neurosciences (G.B., L.R., C.N.), Department of Biology (E.L., L.V., S.C.E.T.), University of Padua, Padova; Epilepsy Centre (L.S., A.C., S.S.), Department of Neurological Sciences, Federico II University, Napoli; and Department of Neurological Sciences (R.M.), Bellaria Hospital, Bologna, Italy.
  • A. Coppola
    From the Muscular and Neurodegenerative Diseases Unit (P.S.), “G. Gaslini” Institute, University of Genoa, Genova; CNR-Istitute of Neurosciences (G.B., L.R., C.N.), Department of Biology (E.L., L.V., S.C.E.T.), University of Padua, Padova; Epilepsy Centre (L.S., A.C., S.S.), Department of Neurological Sciences, Federico II University, Napoli; and Department of Neurological Sciences (R.M.), Bellaria Hospital, Bologna, Italy.
  • L. Vitiello
    From the Muscular and Neurodegenerative Diseases Unit (P.S.), “G. Gaslini” Institute, University of Genoa, Genova; CNR-Istitute of Neurosciences (G.B., L.R., C.N.), Department of Biology (E.L., L.V., S.C.E.T.), University of Padua, Padova; Epilepsy Centre (L.S., A.C., S.S.), Department of Neurological Sciences, Federico II University, Napoli; and Department of Neurological Sciences (R.M.), Bellaria Hospital, Bologna, Italy.
  • L. Rigon
    From the Muscular and Neurodegenerative Diseases Unit (P.S.), “G. Gaslini” Institute, University of Genoa, Genova; CNR-Istitute of Neurosciences (G.B., L.R., C.N.), Department of Biology (E.L., L.V., S.C.E.T.), University of Padua, Padova; Epilepsy Centre (L.S., A.C., S.S.), Department of Neurological Sciences, Federico II University, Napoli; and Department of Neurological Sciences (R.M.), Bellaria Hospital, Bologna, Italy.
  • R. Michelucci
    From the Muscular and Neurodegenerative Diseases Unit (P.S.), “G. Gaslini” Institute, University of Genoa, Genova; CNR-Istitute of Neurosciences (G.B., L.R., C.N.), Department of Biology (E.L., L.V., S.C.E.T.), University of Padua, Padova; Epilepsy Centre (L.S., A.C., S.S.), Department of Neurological Sciences, Federico II University, Napoli; and Department of Neurological Sciences (R.M.), Bellaria Hospital, Bologna, Italy.
  • S.C.E. Tosatto
    From the Muscular and Neurodegenerative Diseases Unit (P.S.), “G. Gaslini” Institute, University of Genoa, Genova; CNR-Istitute of Neurosciences (G.B., L.R., C.N.), Department of Biology (E.L., L.V., S.C.E.T.), University of Padua, Padova; Epilepsy Centre (L.S., A.C., S.S.), Department of Neurological Sciences, Federico II University, Napoli; and Department of Neurological Sciences (R.M.), Bellaria Hospital, Bologna, Italy.
  • S. Striano
    From the Muscular and Neurodegenerative Diseases Unit (P.S.), “G. Gaslini” Institute, University of Genoa, Genova; CNR-Istitute of Neurosciences (G.B., L.R., C.N.), Department of Biology (E.L., L.V., S.C.E.T.), University of Padua, Padova; Epilepsy Centre (L.S., A.C., S.S.), Department of Neurological Sciences, Federico II University, Napoli; and Department of Neurological Sciences (R.M.), Bellaria Hospital, Bologna, Italy.
  • C. Nobile
    From the Muscular and Neurodegenerative Diseases Unit (P.S.), “G. Gaslini” Institute, University of Genoa, Genova; CNR-Istitute of Neurosciences (G.B., L.R., C.N.), Department of Biology (E.L., L.V., S.C.E.T.), University of Padua, Padova; Epilepsy Centre (L.S., A.C., S.S.), Department of Neurological Sciences, Federico II University, Napoli; and Department of Neurological Sciences (R.M.), Bellaria Hospital, Bologna, Italy.

収録刊行物

  • Neurology

    Neurology 76 (13), 1173-1176, 2011-03-29

    Ovid Technologies (Wolters Kluwer Health)

被引用文献 (5)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ